Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 4
- 0 vs. Q1 2024
- Portfolio value
- $55.3M
- −$47.4M (−46.1%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KYTXKyverna Therapeutics, Inc. | COM | 3,255,426 | $24.4M | 44.2% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 4,214,498 | $16.9M | 30.5% | 00.0% | Unchanged | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $12.0M | 21.7% | 00.0% | Unchanged | History |
| TBIOTelesis Bio Inc. | COM NEW | 546,897 | $2.00M | 3.6% | 00.0% | UnchangedConverted for a 1-for-18 split | History |